ArticleBMC cardiovascular disorders2025
Developing and validation of the Sexual Fear Scale in Chinese patients with coronary heart disease.
Article in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundSexual fear in patients with coronary heart disease (CHD) can negatively affect their sexual life and overall well-being. However, validated tools for assessing this fear are lacking. This study aimed to develop a sexual fear scale for patients with CHD and evaluate its psychometric properties.
methodsA multi-stage cross-sectional study was conducted with 409 patients. The process included item generation (literature review, expert consultation, and patient interviews), item selection (critical ratio, correlation analysis, and internal consistency), and psychometric evaluation (content validity, reliability, criterion validity, and construct validity via exploratory and confirmatory factor analysis).
resultsFinally, a 19-item scale including 2 dimensions of perceived risk and fear psychology was formed. After reliability and validity test, the content validity index of the scale is 0.942, Cronbach's α coefficient is 0.944, test-retest reliability is 0.886, and split-half reliability is 0.841. Two factors extracted from exploratory factor analysis explained 58.655% of the total variation, and confirmatory factor analysis showed that the model fit well.
conclusionsThe developed scale demonstrates sound reliability and validity and provides a practical tool for assessing sexual fear in CHD patients, supporting early identification and personalized intervention. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.